NasdaqCM - Nasdaq Real Time Price USD
Purple Biotech Ltd (PPBT)
2.4350
-0.0250
(-1.02%)
As of 11:57:32 AM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-11,263
-14,367
-19,925
-16,735
-15,251
Investing Cash Flow
454
509
13,881
19,914
13,406
Financing Cash Flow
6,609
6,774
5,449
1,114
1,512
Cash Flow from Discontinued Operation
--
--
--
--
-374
End Cash Position
5,785
7,401
14,489
15,030
10,890
Capital Expenditure
--
--
-3
-228
-115
Issuance of Capital Stock
5,656
5,809
1,563
1,498
564
Repayment of Debt
-191
-183
-168
-165
-153
Free Cash Flow
-11,263
-14,367
-19,928
-16,963
-15,366
12/31/2021 - 11/20/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CANF Can-Fite BioPharma Ltd.
1.0700
-0.93%
BLRX.TA BioLineRx Ltd.
3.1000
-6.06%
OSRH OSR Holdings, Inc.
1.5000
-7.98%
CMMB Chemomab Therapeutics Ltd.
1.1907
-2.40%
PLUR Pluri Inc.
4.3700
+1.63%
QLGN Qualigen Therapeutics, Inc.
3.7900
-0.84%
BOLD Boundless Bio, Inc.
1.0800
-0.92%
ENLV Enlivex Therapeutics Ltd.
0.9200
-2.13%
SNTI Senti Biosciences, Inc.
2.6883
-7.30%
MRZM Marizyme, Inc.
0.0081
+2,600.00%